I
IDYA
Ideaya Biosciences
29.10
-0.44-1.49%After Hours: 29.10 0.00 0.00%16:56 05/22 EDT
OPEN/PREV CLOSE29.34/29.54
TODAY RANGE29.06-29.90
VOL450.52K
MARKET CAP2.56B
52 WEEK RANGE17.17-39.28
AVG VOL (3M)1.16M
% TURNOVER0.51%
TURNOVER--
P/E (TTM)-18.2182
% RANGE2.79%
EPS(TTM)-1.5973
P/E(FORWARD)-6.3399
P/B2.728
BVPS10.67
DIVIDEND--
P/S11.68
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.50B
SHARES OUTSTANDING87.86M
NEXT EARNINGS08/03-08/07
FREE FLOAT85.75M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
A Look At IDEAYA Biosciences (IDYA) Valuation After Darovasertib OptimUM-02 And Pipeline Updates
Simply Wall St·05/16 09:42
Will Widened Q1 Loss and New Shelf Registration Change IDEAYA Biosciences’ (IDYA) Funding Narrative?
TipRanks·05/10 02:01
IDEAYA Biosciences (IDYA) Receives a Buy from LifeSci Capital
Simply Wall St·05/08 14:01
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Just Reported And Analysts Have Been Cutting Their Estimates
TipRanks·05/07 15:52
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
Dow Jones·05/07 12:41
IDEAYA Biosciences Is Maintained at Outperform by Mizuho
Dow Jones·05/07 12:41
IDEAYA Biosciences Price Target Cut to $50.00/Share From $52.00 by Mizuho
Benzinga·05/07 12:32
Mizuho Maintains Outperform on IDEAYA Biosciences, Lowers Price Target to $50
Simply Wall St·05/07 10:34
Some Analysts Just Cut Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Estimates
TipRanks·05/06 12:16
RBC Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)
Simply Wall St·05/06 05:29
IDEAYA Biosciences (IDYA) Persistent Losses Challenge Bullish High Revenue Growth Narratives
TipRanks·05/05 23:12
IDEAYA Biosciences Files New Shelf Registration Statement